Together, they create both an amplified and prolonged GH response, which supports metabolism, lean muscle growth, fat reduction, energy, and recovery
Glucagon-like peptide-1 (GLP-1) agonists are a class of medications originally developed to manage type 2 diabetes mellitus and, more recently, obesity
This stability profile distinguishes it from many peptide-based research compounds and has contributed to interest in its biochemical persistence, signaling activity, and pathway-specific effects in mechanistic investigations
doi: 10.1183/09031936.00000106 181 YangWSSriRamaratnamRWelschMEShimadaKSkoutaRViswanathanVSet al
Another ideal characteristic should be that the drug acts pleiotropically, improving other clinical aspects such as control of blood pressure or lipids, quite often associated with obesity [34]